Journal
Blood Advances
Publication Date
9-26-2023
Volume
7
Issue
18
First Page
5320
Last Page
5324
Document Type
Open Access Publication
DOI
10.1182/bloodadvances.2023010223
Rights and Permissions
Lakhotia R, Dunleavy K, Abramson JS, Link BK, Powell BL, Melani C, Lucas AN, Steinberg SM, Friedberg JW, Kahl BS, Little RF, Bartlett NL, Noy A, Wilson WH, Roschewski M. Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R. Blood Adv. 2023 Sep 26;7(18):5320-5324. doi: 10.1182/bloodadvances.2023010223. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution.
Recommended Citation
Lakhotia, Rahul; Dunleavy, Kieron; Abramson, Jeremy S; Link, Brian K; Powell, Bayard L; Melani, Christopher; Lucas, Andrea N; Steinberg, Seth M; Friedberg, Jonathan W; Kahl, Brad S; Little, Richard F; Bartlett, Nancy L; Noy, Ariela; Wilson, Wyndham H; and Roschewski, Mark, "Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R." Blood Advances. 7, 18. 5320 - 5324. (2023).
https://digitalcommons.wustl.edu/oa_4/2313
